comprehensive -WSS

comprehensive

author：fashion 2025-10-04 03:59:35 - browse：6651

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Russian and Belarusian players banned from a women's tennis tournament in Prague

Wikipedia

hotspot

WSS

Private equity deals in Medicare Advantage declines

Vaccine advisory panel ACIP left half staffed by HHS

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Doctors increasingly discourage vaping amid mounting health concerns

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Industry veterans launch new biotech VC with $310M

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Senators start work on Medicare physician payment reform

The high cost of giving birth even with insurance

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Peter Hotez and the public health issue of online harassment

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Virginia high school admissions case could be legal follow

BioAge raises $170M for combination therapy with Zepbound

entertainment

Key House Republican on health care plans exit from Congress

BioAge raises $170M for combination therapy with Zepbound

Doctors increasingly discourage vaping amid mounting health concerns

Doctors' information doesn't help them choose wisely when sick

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Wikipedia

hotspot

focus

entertainment